StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)

Close on Nov 17, 2026Market cap $4.48BP/E –Yield –

Ionis Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ionis Pharmaceuticals's price to sales ratio was 5.4× on Nov 11, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 5.4× to 14.0×, with a median of 8.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.4×−7.8
2025Dec 31, 202513.2×+6.3
2024Dec 31, 20246.9×−4.9
2023Dec 29, 202311.8×+5.7
2022Dec 30, 20226.1×−0.4
2021Dec 31, 20216.5×−2.0
2020Dec 31, 20208.5×−1.9
2019Dec 31, 201910.3×−2.6
2018Dec 31, 201812.9×+0.6
2017Dec 29, 201712.4×−12.0
2016Dec 30, 201624.4×+0.9
2015Dec 31, 201523.4×−19.0
2014Dec 31, 201442.5×+5.5
2013Dec 31, 201337.0×+27.8
2012Dec 31, 20129.2×+1.5
2011Dec 30, 20117.7×−1.1
2010Dec 31, 20108.8×−1.0
2009Dec 31, 20099.8×–

More Ionis Pharmaceuticals figures

See a number that looks wrong?